Medifast, Inc. (NYSE:MED) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET

Company Participants

Steve Zenker - Vice President of Investor Relations

Dan Chard - Chairman & Chief Executive Officer

Jim Maloney - Chief Financial Officer

Conference Call Participants

Linda Bolton-Weiser - D.A. Davidson

Operator

Good afternoon, and welcome to the Medifast First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.

I would now like to turn the conference over to Steve Zenker, Medifast's Vice President of Investor Relations. Please, go ahead.

Steve Zenker

Good afternoon, and welcome to Medifast's first quarter 2023 earnings conference call. On the call with me today are Dan Chard, Chairman and Chief Executive Officer; and Jim Maloney, Chief Financial Officer.

By now, everyone should have access to the earnings release for the quarter ended March 31, 2023, that went out this afternoon at approximately 4:05 PM Eastern Time. If you have not received the release, it is available on the Investor Relations portion of Medifast's website at www.medifastinc.com. This call is being webcast, and a replay will also be available on the company's website.

Before we begin, we would like to remind everyone that today's prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions. The words believe, expect, anticipate and other similar expressions generally identify forward-looking statements. These statements do not guarantee future performance, and therefore, undue reliance should not be placed on them.

Actual results could differ materially from those projected in any forward-looking statements. All the forward-looking statements contained herein speak only as of the date of this call. Medifast assumes no obligation to update any forward-looking statements that may be made in today's release or call.

And with that, I would like to turn the call over to Medifast's Chairman and Chief Executive Officer, Dan Chard.

Dan Chard

Thanks, Steve. For those of you who missed the announcement in March, Steve Zenker joined the company earlier in the year as our new Vice President of Investor Relations. Sharing the Medifast story with investors is a key priority for us, and we're very happy to have Steve on the team to help us elevate our Investor Relations efforts and investment community interactions. Let me start by thanking you for joining us on the call today. We appreciate your time and interest in Medifast.